(Q84444056)
Statements
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy (English)
Gwyn Bebb
Colum Smith
Stewart Rorke
William Boland
Leonardo Nicacio
Ryan Sukhoo